Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Guselkumab Real-world Effectiveness Among Bio-NaÏve Patients With Moderate-to-severe Ulcerative Colitis in China: A Multicenter, Non-interventional, Prospective Study

NCT07302360 is registered in ClinicalTrials.gov with Xian-Janssen Pharmaceutical Ltd. as lead sponsor.

NCT NCT07302360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07302360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Guselkumab Real-world Effectiveness Among Bio-NaÏve Patients With Moderate-to-severe Ulcerative Colitis in China: A Multicenter, Non-interventional, Prospective Study
Lead sponsor
Xian-Janssen Pharmaceutical Ltd.
Phase
Observational
Overall status
Recruiting
Start date
December 11, 2025
Completion date
June 30, 2028
Enrollment
200 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

colitis, ulcerative